Sellmer Laura, Farschtschi Said, Marangoni Marco, Heran Manraj K S, Birch Patricia, Wenzel Ralph, Friedman Jan M, Mautner Victor-Felix
Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
Department of Neurology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Orphanet J Rare Dis. 2017 Feb 15;12(1):34. doi: 10.1186/s13023-017-0588-2.
Non-optic gliomas occur in 5% of children with NF1, but little is known about these tumours in adults. We aimed to investigate progression, spontaneous regression and the natural history of non-optic gliomas in adults and compare these findings to the results found in children.
One thousand seven hundred twenty-two brain MRI scans of 562 unselected individuals with NF1 were collected at the NF outpatient department of the University Hospital Hamburg-Eppendorf between 2003 and 2015. The number of scans per patient ranged from one to 12; patients were followed for a median of 3.7 years. We identified 24 patients (4.3%) with non-optic gliomas. Median age at first scan with glioma was 21.2 years, much higher than in previous publications. Only seven of the 24 non-optic glioma patients were symptomatic. Five of 24 patients had multiple non-optic gliomas. Four individuals developed a new tumour, and 4 cases showed progression. The risk of new tumour development was 0.19% (95% confidence interval 0.06% to 0.52%) per patient year of follow-up for patients over 10 years. The rate of progressing non-optic gliomas per patient year of follow-up in the first 5 years after tumour diagnosis was 4.7% (95% confidence interval 1.5% to 12%).
Non-optic gliomas are twice as common in an unselected cohort of NF1 patients as previously reported. This is likely due to increased frequency of diagnosis of asymptomatic tumours when routine MRIs are performed and a higher prevalence in older individuals.
非视神经胶质瘤发生于5%的1型神经纤维瘤病(NF1)儿童患者中,但对于成人患者中的这些肿瘤了解甚少。我们旨在研究成人非视神经胶质瘤的进展、自发消退及自然史,并将这些结果与儿童患者的结果进行比较。
2003年至2015年间,在汉堡-埃彭多夫大学医院的NF门诊收集了562例未经选择的NF1患者的1722份脑部MRI扫描图像。每位患者的扫描次数从1次到12次不等;患者的中位随访时间为3.7年。我们识别出24例(4.3%)患有非视神经胶质瘤的患者。首次扫描发现胶质瘤时的中位年龄为21.2岁,远高于以往的报道。24例非视神经胶质瘤患者中只有7例有症状。24例患者中有5例患有多发性非视神经胶质瘤。4例患者出现了新的肿瘤,4例显示病情进展。对于10岁以上的患者,随访期间每位患者每年发生新肿瘤的风险为0.19%(95%置信区间为0.06%至0.52%)。肿瘤诊断后的前5年,每位患者每年非视神经胶质瘤进展的发生率为4.7%(95%置信区间为1.5%至12%)。
在未经选择的NF1患者队列中,非视神经胶质瘤的发生率是先前报道的两倍。这可能是由于进行常规MRI检查时无症状肿瘤的诊断频率增加以及老年个体中的患病率较高。